This is not an arbitrary number
LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al
Watch out and discuss with your doctor
Traditional recovery methods-such as ice baths, stretching, and protein intake-have their place, but many athletes are turning to more advanced tools to support performance and healing
Disclaimer: This product is strictly for laboratory research use only
Storage Requirements Proper storage conditions are critical for preserving peptide quality and maintaining long-term product performance